Literature DB >> 12503799

Treatment of post-traumatic ankle arthrosis with bipolar tibiotalar osteochondral shell allografts.

Choll W Kim1, Amir Jamali, William Tontz, F Richard Convery, Michael E Brage, William Bugbee.   

Abstract

We report on tibiotalar osteochondral shell allografts for post-traumatic ankle arthropathy in seven patients. Average follow-up was 148 months (range, 85 to 198). Patients were evaluated by a questionnaire, SF-12 survey, ankle score, physical exam and radiographs. The ankle score increased from 25 preoperatively to 43 at latest follow-up (maximum score 100). SF-12 scores increased from 30 to 38 (Physical Component) and 46 to 53 (Mental Component). The failure rate was 42%. Four of seven patients reported good or excellent results. Five patients stated they would undergo a similar procedure again. Complications included graft fragmentation, poor graft fit, graft subluxation, and non-union. Follow-up radiographs demonstrated joint space narrowing, osteophytes, and sclerosis, even in cases with excellent clinical status. Fresh osteochondral shell allografting may provide a viable alternative for the treatment of post-traumatic ankle arthrosis in selected individuals.

Entities:  

Mesh:

Year:  2002        PMID: 12503799     DOI: 10.1177/107110070202301203

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  10 in total

1.  Intermediate-term follow-up after ankle distraction for treatment of end-stage osteoarthritis.

Authors:  Mai P Nguyen; Douglas R Pedersen; Yubo Gao; Charles L Saltzman; Annunziato Amendola
Journal:  J Bone Joint Surg Am       Date:  2015-04-01       Impact factor: 5.284

2.  Bipolar fresh osteochondral allograft for the treatment of glenohumeral post-traumatic arthritis.

Authors:  Sandro Giannini; Roberto Buda; Marco Cavallo; Alberto Ruffilli; Brunella Grigolo; Pier Maria Fornasari; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-24       Impact factor: 4.342

3.  Total femoral and tibial osteochondral allograft for remobilizing a knee after arthrodesis.

Authors:  Sandro Giannini; Roberto Buda; Alberto Ruffilli; Gherardo Pagliazzi; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-09-27       Impact factor: 4.342

Review 4.  Clinical applications of allografts in foot and ankle surgery.

Authors:  Pedro Diniz; Jácome Pacheco; Miguel Flora; Diego Quintero; Sjoerd Stufkens; Gino Kerkhoffs; Jorge Batista; Jon Karlsson; Hélder Pereira
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-05       Impact factor: 4.342

5.  Bipolar fresh osteochondral allograft of the shoulder.

Authors:  Sandro Giannini; Elisa Sebastiani; Alba Shehu; Matteo Baldassarri; Susanna Maraldi; Francesca Vannini
Journal:  Joints       Date:  2014-03-21

6.  Failures in bipolar fresh osteochondral allograft for the treatment of end-stage knee osteoarthritis.

Authors:  S Giannini; R Buda; A Ruffilli; G Pagliazzi; A Ensini; B Grigolo; G Desando; F Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-04       Impact factor: 4.342

7.  Bipolar Osteochondral Allograft Transplantation of the Tibiotalar Joint for Ankle Arthritis.

Authors:  William D Bugbee; Michael E Brage
Journal:  JBJS Essent Surg Tech       Date:  2014-02-12

8.  Immunologic testing of xeno-derived osteochondral grafts using peripheral blood mononuclear cells from healthy human donors.

Authors:  Vincent J Hetherington; Jill S Kawalec; Douglas S Dockery; Oleg S Targoni; Paul V Lehmann; Daniel Nadler
Journal:  BMC Musculoskelet Disord       Date:  2005-06-29       Impact factor: 2.362

9.  Osteochondral Allografts in the Ankle Joint: State of the Art.

Authors:  Francesca Vannini; Roberto Buda; Gherardo Pagliazzi; Alberto Ruffilli; Marco Cavallo; Sandro Giannini
Journal:  Cartilage       Date:  2013-07       Impact factor: 4.634

10.  Immunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive mice.

Authors:  Jill S Kawalec-Carroll; Vincent J Hetherington; Douglas S Dockery; Carey Shive; Oleg S Targoni; Paul V Lehmann; Daniel Nadler; Dustin Prins
Journal:  BMC Musculoskelet Disord       Date:  2006-03-17       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.